EUVIMEDEUVIMED entdecken
Open Access

Bicyclic temporin L peptide inhibitors targeting the SARS-CoV-2 main protease: design, synthesis, in vitro inhibition efficiency and molecular dynamics insights

Md Taimuzzaman Sharif, Md Omor Farque, Md Habibur Rahaman, Md Arafat Hossen iD, Mohammed Akhter Hossain iD, Mohammad A Halim iD

RSC Medicinal Chemistry · 2025 · 16 (11) · 5456-5471

DOI: 10.1039/d5md00528k ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2025. Verfasst von Md Taimuzzaman Sharif und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, Kennesaw State University Kennesaw GA 30144 USA mhalim1@kennesaw.edu. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Kennesaw State University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TBMB linker containing bicyclic temporin L peptide with three cysteine residues. 3D structure of the bicyclic peptide and its interaction with the main protease of SARS-CoV-2.

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, Kennesaw State University Kennesaw GA 30144 USA mhalim1@kennesaw.edu.
  • Division of Infectious Diseases and Division of Computer-Aided Drug Design, The Red-Green Research Center, BICCB Tejgaon 1215 Dhaka Bangladesh.
  • The Florey, University of Melbourne Melbourne Victoria 3010 Australia.

ORCID-Profile: Md Arafat Hossen, Mohammed Akhter Hossain, Mohammad A Halim

Förderung

  • Kennesaw State University

Zitieren

APA

Sharif, M. T., Farque, M. O., Rahaman, M. H., Hossen, M. A., Hossain, M. A., & Halim, M. A. (2025). Bicyclic temporin L peptide inhibitors targeting the SARS-CoV-2 main protease: design, synthesis, in vitro inhibition efficiency and molecular dynamics insights. RSC Medicinal Chemistry, 16(11), 5456-5471. https://doi.org/10.1039/d5md00528k

Vancouver

Sharif MT, Farque MO, Rahaman MH, Hossen MA, Hossain MA, Halim MA. Bicyclic temporin L peptide inhibitors targeting the SARS-CoV-2 main protease: design, synthesis, in vitro inhibition efficiency and molecular dynamics insights. RSC Medicinal Chemistry. 2025;16(11):5456-5471. doi:10.1039/d5md00528k

BibTeX
@article{Sharif2025,
  author = {Sharif, Md Taimuzzaman and Farque, Md Omor and Rahaman, Md Habibur and Hossen, Md Arafat and Hossain, Mohammed Akhter and Halim, Mohammad A},
  title = {Bicyclic temporin L peptide inhibitors targeting the SARS-CoV-2 main protease: design, synthesis, in vitro inhibition efficiency and molecular dynamics insights},
  journal = {RSC Medicinal Chemistry},
  year = {2025},
  volume = {16},
  number = {11},
  pages = {5456--5471},
  doi = {10.1039/d5md00528k}
}
Kostenlos starten →